Revvity Gross Profit 2010-2024 | RVTY

Revvity annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Revvity gross profit for the quarter ending December 31, 2024 was $0.412B, a 7.51% increase year-over-year.
  • Revvity gross profit for the twelve months ending December 31, 2024 was $1.538B, a 0.13% decline year-over-year.
  • Revvity annual gross profit for 2024 was $1.538B, a 0.13% decline from 2023.
  • Revvity annual gross profit for 2023 was $1.54B, a 22.62% decline from 2022.
  • Revvity annual gross profit for 2022 was $1.99B, a 18.25% decline from 2021.
Revvity Annual Gross Profit
(Millions of US $)
2024 $1,538
2023 $1,540
2022 $1,990
2021 $2,434
2020 $1,730
2019 $1,396
2018 $1,341
2017 $1,074
2016 $1,014
2015 $964
2014 $935
2013 $976
2012 $962
2011 $848
2010 $759
2009 $701
Revvity Quarterly Gross Profit
(Millions of US $)
2024-12-31 $412
2024-09-30 $385
2024-06-30 $386
2024-03-31 $355
2023-12-31 $383
2023-09-30 $373
2023-06-30 $402
2023-03-31 $381
2022-12-31 $436
2022-09-30 $407
2022-06-30 $552
2022-03-31 $595
2021-12-31 $441
2021-09-30 $523
2021-06-30 $685
2021-03-31 $785
2020-12-31 $447
2020-09-30 $527
2020-06-30 $447
2020-03-31 $308
2019-12-31 $398
2019-09-30 $342
2019-06-30 $348
2019-03-31 $308
2018-12-31 $376
2018-09-30 $332
2018-06-30 $340
2018-03-31 $292
2017-12-31 $307
2017-09-30 $269
2017-06-30 $258
2017-03-31 $240
2016-12-31 $277
2016-09-30 $249
2016-06-30 $254
2016-03-31 $235
2015-12-31 $222
2015-09-30 $255
2015-06-30 $253
2015-03-31 $235
2014-12-31 $208
2014-09-30 $243
2014-06-30 $248
2014-03-31 $236
2013-12-31 $276
2013-09-30 $233
2013-06-30 $242
2013-03-31 $225
2012-12-31 $260
2012-09-30 $231
2012-06-30 $239
2012-03-31 $232
2011-12-31 $239
2011-09-30 $199
2011-06-30 $209
2011-03-31 $200
2010-12-31 $208
2010-09-30 $186
2010-06-30 $189
2010-03-31 $175
2009-12-31 $156
2009-09-30 $169
2009-06-30 $188
2009-03-31 $189
Sector Industry Market Cap Revenue
Medical Medical Services $12.712B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.516B 27.37
Elevance Health (ELV) United States $98.469B 13.19
CVS Health (CVS) United States $85.419B 12.50
Cencora (COR) United States $53.926B 19.57
DiDi Global (DIDIY) China $23.525B 0.00
Natera (NTRA) United States $19.117B 0.00
BioMerieux (BMXMF) France $14.914B 0.00
ICON (ICLR) Ireland $14.132B 12.84
Solventum (SOLV) United States $13.154B 12.27
Avantor (AVTR) United States $11.045B 16.21
CochLear (CHEOY) Australia $10.877B 0.00
Doximity (DOCS) United States $10.834B 56.34
EUROFINS SCIENT (ERFSF) Luxembourg $10.609B 0.00
Viatris (VTRS) United States $10.397B 3.29
Medpace Holdings (MEDP) United States $9.283B 24.12
Sonic Healthcare (SKHHY) Australia $7.768B 0.00
Charles River Laboratories (CRL) United States $7.697B 14.59
HealthEquity (HQY) United States $7.644B 37.60
Bausch + Lomb (BLCO) Canada $5.111B 23.39
Amplifon S.p.A (AMFPF) Italy $4.961B 26.19
Organon (OGN) United States $3.841B 3.91
Alignment Healthcare (ALHC) United States $3.572B 0.00
Sotera Health (SHC) United States $3.305B 19.11
BrightSpring Health Services (BTSG) United States $3.165B 32.89
Surgery Partners (SGRY) United States $3.031B 34.93
Concentras Parent (CON) United States $2.781B 14.47
GeneDx Holdings (WGS) United States $2.486B 295.22
Ardent Health Partners (ARDT) United States $1.963B 0.00
Progyny (PGNY) United States $1.908B 42.15
Agilon Health (AGL) United States $1.785B 0.00
Premier (PINC) United States $1.760B 11.27
PACS (PACS) United States $1.713B 0.00
GoodRx Holdings (GDRX) United States $1.692B 36.75
Teladoc Health (TDOC) United States $1.382B 0.00
Pediatrix Medical (MD) United States $1.243B 10.42
Establishment Labs Holdings (ESTA) $1.177B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.031B 0.00
CareDx (CDNA) United States $0.984B 16.75
AMN Healthcare Services Inc (AMN) United States $0.934B 7.39
Embecta (EMBC) United States $0.741B 5.08
QDM (QDMI) Hong Kong, SAR China $0.526B 13.77
Auna S.A (AUNA) Luxembourg $0.526B 13.94
Enhabit (EHAB) United States $0.444B 41.86
Sonida Senior Living (SNDA) United States $0.441B 0.00
InnovAge Holding (INNV) United States $0.403B 0.00
SBC Medicals (SBC) United States $0.329B 0.00
DocGo (DCGO) United States $0.269B 11.00
COMPASS Pathways (CMPS) United Kingdom $0.265B 0.00
Nutex Health (NUTX) United States $0.256B 5.10
LifeMD (LFMD) United States $0.243B 0.00
Performant Healthcare (PHLT) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.168B 0.00
Sera Prognostics (SERA) United States $0.139B 0.00
So-Young (SY) China $0.098B 0.00
Biodesix (BDSX) United States $0.091B 0.00
Basel Medical Group (BMGL) Singapore $0.090B 0.00
OncoCyte (OCX) United States $0.088B 0.00
Oncology Institute (TOI) United States $0.086B 0.00
Ascend Wellness Holdings (AAWH) United States $0.075B 0.00
IceCure Medical (ICCM) Israel $0.065B 0.00
NeueHealth (NEUE) United States $0.056B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.026B 0.00
Pheton Holdings (PTHL) China $0.024B 0.00
ModivCare (MODV) United States $0.019B 6.57
SeaStar Medical Holding (ICU) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
KindlyMD (KDLY) United States $0.010B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.001B 0.00
Aclarion (ACON) United States $0.000B 0.00
Cano Health (CANOQ) United States $0.000B 0.00